Seeking Alpha 5/22/13 By:George RHO
All in all, our assumptions and projections would have to be considerably off the mark for MNKD stock not to have substantial upside potential. It should be noted, too, that our figures could prove to be very conservative.
Yahoo Finance May 20, 2013
Price Target Summary
Median Target: 34.00High Target: 40.00
No. of Brokers: 28
give me a break.. it goes right back up everytime.
Great Article, Won't Let me Post.. Says bad buy and misguided, advertisers won't use because of it's content. Great Read Just Google Title into Google.
Article :All Yahoo's spending can't make it cool again
May 20, 2013
It's time for the Web 1.0 icon to put down its credit card and get back to work.
By Cyrus Sanati
Experimental Gilead drug effective in early-stage leukemia trial Reuters
Wed May 15, 2013 5:59pm EDT
By Deena Beasley
May 15 (Reuters) - An experimental drug from Gilead Sciences Inc shrank tumors in half of leukemia patients whose cancer had returned, according to an early-stage trial that represents a new foray into oncology by the world's biggest seller of HIV medications.
The pill, idelalisib, is part of a new class of medications designed to selectively block a type of protein known to promote tumor growth in patients with chronic lymphocytic leukemia (CLL) and other types of blood cancer.
The "pretty incredible" results illustrate how a growing understanding of tumor biology is helpingresearchers develop promising new targeted drugs, said Dr Sandra Swain, president of the American Society of Clinical Oncology, which will feature the research at its conference in Chicago later this month.
I disagree, big news out after hours and run up for Asco, we are just getting started.
5/9/13 Earnings Yahoo Finance
Yahoo News 5/9/13
Best comment by CG: We believe the FDA will partner with us to get this product to patients who need it
wouldn't add suppliers if drug sales were down.